Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 220 - файл

.pdf
Скачиваний:
0
Добавлен:
28.08.2026
Размер:
86 Мб
Скачать
F
3.5 Treatment
https://t.me/medicina_free
67
Burst abdomen in pregnancy (post laparotomy; post incisional hernia etc)
<24 weeks
Intra-abdominal sepsis
Ye s
Fetus alive
Ye s
SM NPWT/BB SVD/CS when possible EHR
NPWT/BB + EHR
Fetus aliveFetus aliv
No
SM
TOP
Ye s
NPWT/BB CS/SVD Mesh repair
TOP + 1º mesh repair
No
Fig. 3.10 Management algorithm for burst abdomen in pregnancy. SVD spontaneous vaginal delivery, NPWT negative pressure wound therapy, CS cesarean section, TOP termination of pregnancy, SM surgical management
Fig. 3.11 Intra­abdominal pressure before Cesarean section
403020
(preoperative) and postoperative (every 30min during 2h). (Reproduced with permission from [30] under the CC Attribution Licence)
>24 weeks
Intra-abdominal sepsis
Ye sNo
SVD/CS when possible
NPWT/BB
Ye s
NPWT/BB CS/SVD with Mesh repair
No
e etus alive
No
C/S 1º mesh repair
No
SM
C/S
NPWT/BB
EHR
involves laparotomy and peritoneal lavage if required, BB bogota bag, EHR elective hernia repair. (Reproduced with permission from [118])
Ye s
SM
EHR
100
Intra-abdominal pressure (mmHg)
IAP preoperative IAP M30 IAP M90
IAP M0 IAP M60 IAP M120
68
https://t.me/medicina_free
3 Increased Intra-abdominal Pressure
3.6 Prognosis
3.6.1 Maternal Outcome
The maternal outcome depends on:
• the severity and duration of IAH/ACS,
• the cause of increased IAP,
• normalization of IAP after delivery.
Despite the presence of risk factors for IAH in ICU obstetric patients, the prevalence of IAH (IAP >12 mmHg) was only 6%, while 66% of patients had IAP 8–11mmHg. Interestingly, this is much lower than for mixed, nonpregnant populations of critically ill patients in the ICU (19–80%) [9].
The usual IAP may be slightly higher in criti­cally ill obstetric patients than in mixed popula­tions of critically ill patients. Nevertheless, IAP does not affect organ function depicted by the SOFA score, and the low prevalence of IAH pre­vented the evaluation of affected organ dysfunc­tion [9]. The prevalence of IAH was 75% in pregnant and 0% in postpartum patients.
and a mean IAP of 21.7mmHg. Maternal mortal­ity was 0% [121, 150].
3.6.2 Fetal Outcome
3.6.2.1 Burst Abdomen
Fetal mortality depends on (1) the gravid uterus incarceration at presentation and (2) gestation of less than 24weeks [114, 117, 118, 153].
3.6.2.2 Acute Pancreatitis
A study of 17 pregnant women with acute pan­creatitis in the third trimester (with 47% due to hyperlipidemia) found a high prevalence of IAH, with a mean IAP of 16.7 mmHg [121]. Two (12%) developed ACS, with organ dysfunction and a mean IAP of 21.7mmHg. Fetal mortality was 31.2%, and higher maternal IAP correlated with higher fetal mortality.
3.6.2.3 Acute Appendicitis
Both patients were in the second trimester. Neither received tocolysis, and neither went to preterm labor [122, 123]. Deliveries were uneventful, and both children had normal development.
Following delivery, a fall in IAP is associ-
ated with better survival [9].
3.6.1.1 Burst Abdomen
Various methods for (temporary) closure of burst abdomen in pregnancy were used: two cases with negative pressure wound therapy [117, 153], one with the mesh [114] and one with Bogota beg [118]. Maternal mortality was 0%.
3.6.1.2 Acute Pancreatitis
The development of IAH/ACS among patients with severe acute pancreatitis in the general pop­ulation is a strong predictor of mortality up to 49% [156]. A study of 17 pregnant women with acute pancreatitis in the third trimester (47% due to hyperlipidemia) found a high prevalence of IAH, with a mean IAP of 16.7mmHg [121]. Two (12%) developed ACS, with organ dysfunction
3.6.2.4 Obesity
High IAP may compress the maternal aorta and uterine arteries, reducing uterine perfusion pres­sure and fetoplacental insufciency. The higher predelivery IAP was associated with lower new­born NACS (Neurologic and Adaptive Capacity) scores. This association was found most often among women with Class III obesity (BMI 40kg/m2) who received spinal anesthesia [157].
References
1. O’Rourke N, Kodali BS. Laparoscopic sur­gery during pregnancy. Curr Opin Anaesthesiol. 2006;19:254–9.
2. Pollock W, Rose L, Dennis CL.Pregnant and postpar­tum admissions to the intensive care unit: a system­atic review. Intensive Care Med. 2010;36:1465–74.
3. Wanderer JP, Leffert LR, Mhyre JM, Kuklina EV, Callaghan WM, Bateman BT. Epidemiology of obstetric-related ICU admissions in Maryland: 1999-2008. Crit Care Med. 2013;41:1844–52.
References
https://t.me/medicina_free
69
4. Vasco M, Pandya S, Van Dyk D, Bishop DG, Wise R, Dyer RA.Maternal critical care in resource- limited settings. Narrative review. Int J Obstet Anesth. 2019;37:86–95.
5. Staelens ASE, Van Cauwelaert S, Tomsin K, Mesens T, Malbrain MLN, Gyselaers W. Intra-abdominal pressure measurements in term pregnancy and postpartum: an observational study. PLoS One. 2014;9(8):e104782.
6. Malbrain MLNG, De Keulenaer BL, Oda J, De Laet I, De Waele JJ, Roberts DJ, etal. Intra-abdominal hypertension and abdominal compartment syndrome in burns, obesity, pregnancy, and general medicine. Anaesthesiol Intensive Ther. 2015;47:228–40.
7. Zeeman G. Obstetric critical care: a blue­print for improved outcomes. Crit Care Med. 2006;34:S208–14.
8. American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 100: critical care in pregnancy. Obstet Gynecol. 2009;113:443–50.
9. Tyagi A, Singh S, Kumar M, Sethi AK. Intra­abdominal pressure and intra-abdominal hyperten­sion in critically ill obstetric patients: a prospective cohort study. Int J Obstet Anesth. 2017;32:33–40.
10. Paramore R.The intra-abdominal pressure in preg­nancy. Proc R Soc Med. 1913;6:291–334.
11. Gaiser R. Physiologic changes of pregnancy. In: Chestnut L, Tsen L, Wong CDP, editors. Chestnut’s obstetric anesthesia: principles and practice. 4th ed. Philadelphia: Mosby Elsevier; 2009. p.15–26.
12. Bani D. Relaxin: a pleiotropic hormone. Gen Pharmacol. 1997;28:13–22.
13. Suresh MS, Mason CLT, Munnur U. Cardio­pulmonary resuscitation and the parturient. Best Pract Res Clin Obstet Gynaecol. 2010;24:383–400.
14. Scott DB, Kerr MG.Inferior vena caval pressure in late pregnancy. J Obstet Gynaecol Br Commonw. 1963;70:1044–9.
15. Schatz F. Beiträge zur physiologischen Geburtskunde. Arch f Gynäk. 1872;4:418–56.
16. Schroeder C.Handbuch der Krankheiten der weib­lichen Geschlechtsorgan. Leipzig: Vogel; 1886. p.151.
17. Sawchuck DJ, Wittmann BK.Pre-eclampsia renamed and reframed: intra-abdominal hypertension in preg­nancy. Med Hypotheses. 2014;83(5):619–32.
18. Abdel-Razeq SS, Campbell K, Funai EF, Kaplan LJ, Bahtiyar MO. Normative postpartum intraabdomi­nal pressure: potential implications in the diagnosis of abdominal compartment syndrome. Am J Obstet Gynecol. 2010;203(149):e1–4.
19. Chun R, Baghirzada L, Tiruta C, Kirkpatrick AW. Measurement of intra-abdominal pressure in term pregnancy: a pilot study. Int J Obstet Anesth. 2012;21:135–9.
20. Al-Khan M, Shah M, Altabban M, Kaul S, Dyer KY, Alvarez M, Saber S.Measurement of intraabdominal pressure in pregnant women at term. J Reprod Med. 2011;56:53–7.
21. Malbrain ML, Cheatham ML, Kirkpatrick A, etal. Results from the international conference of experts on intra-abdominal hypertension and abdominal compartment syndrome. I. Denitions. Intensive Care Med. 2006;32:1722–32.
22. Kinsella S.Lateral tilt for pregnant women: why 15 degrees? Anaesthesia. 2003;58:835–6.
23. Bamber JH, Dresner M. Aortocaval compression in pregnancy: the effect of changing the degree and direction of lateral tilt on maternal cardiac output. Anesth Analg. 2003;97:256–8.
24. De Keulenaer BL, De Waele JJ, Powell B, Malbrain MLNG. What is normal intra-abdominal pressure and how is it affected by positioning, body mass and positive end-expiratory pressure? Intensive Care Med. 2009;35:969–76.
25. McBeth PB, Zygun DA, Widder S, etal. Effect of patient positioning on intra-abdominal pressure monitoring. Am J Surg. 2007;193:644–7.
26. Cheatham ML, De Waele JJ, De Laet I, etal. The impact of body position on intra-abdominal pressure measurement: a multicenter analysis. Crit Care Med. 2009;37:2187–90.
27. Lozada JM, Goyal V, Levin D, Walden RL, Osmudson SS, Pacheco LD, et al. Management of peripartum intra-abdominal hypertension and abdominal compartment syndrome. Acta Obstet Gynecol Scand. 2019;98:1386–97.
28. Kirkpatrick AW, Roberts DJ, De Waele J, Jaeschke R, Malbrain MLNG, De Keulenaer B, etal. Intra­abdominal hypertension and the abdominal com­partment syndrome: updated consensus denitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome. Intensive Care Med. 2013;39:1190–206.
29. Malbrain MLNG, De Laet IE, De Waele JJ, Kirkpatrick AW. Intra-abdominal hyperten­sion: denitions, monitoring, interpretation and management. Best Pract Res Clin Anaesthesiol. 2013;27(2):249–70.
30. Fuchs F, Bruyere M, Senat M-V, etal. Are standard intra-abdominal pressure values different during pregnancy? PLoS One. 2013;8(10):e77324.
31. Hawkes R, Iqbal J, Mansour F, et al. Physics for scientists and engineers: an interactive approach. Toronto: Nelson College Indigenous; 2014.
32. Mulier JP, Dillemans B, Crombach M, etal. On the abdominal pressure volume relationship. Internet J Anesthesiol. 2009;21:1.
33. Mulier JP, Dillemans B, Heremans L.Determinants of the abdominal pressure volume relation in non ACS patients. Acta Clin Belg. 2007;62(Suppl):289.
34. Sanchez NC, Tenofsky PL, Dort JM, et al. What is normal intra-abdominal pressure? Am Surg. 2001;67:243–8.
35. Gong G, Wang P, Ding W, etal. The role of oxygen­free radical in the apoptosis of enterocytes and bacterial translocation in abdominal compartment syndrome. Free Radic Res. 2009;43:470–7.
70
https://t.me/medicina_free
3 Increased Intra-abdominal Pressure
36. Kaussen T, Srinivasan PK, Afy M, Herweg C, Tolba R, Conze J, et al. Inuence of two different levels of intra-abdominal hypertension on bacte­rial translocation in a porcine model. Ann Intensive Care. 2012;2(Suppl 1):S17.
37. Fasano A, Abreu MT, Agardh D, Nilsson A, Tuomi T, Lindberg B, et al. Zonulin and its regulation of intestinal barrier function: the biological door to inammation, autoimmunity, and cancer. Physiol Rev. 2011;91(1):151–75.
38. Kubiak BD, Albert SP, Gatto LA, et al. A clini­cally applicable porcine model of septic and isch­emia/reperfusion-induced shock and multiple organ injury. J Surg Res. 2011;166:e59–69.
39. Bhattacharyya A, Chattopadhyay R, Mitra S, Crowe SE.Oxidative stress: an essential factor in the patho­genesis of gastrointestinal mucosal diseases. Physiol Rev. 2014;94(2):329–54.
40. Fasano A. Zonulin and its regulation of intesti­nal barrier function: the biological door to inam­mation, autoimmunity, and cancer. Physiol Rev. 2011;91:151–75.
41. Asmar RE, Panigrahi P, Bamford P, et al. Host­dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure. Gastroenterology. 2002;123:1607–15.
42. Curet MJ, Weber DM, Sae A, Lopez J.Effects of helium pneumoperitoneum in pregnant ewes. Surg Endosc. 2001;15:710–4.
43. Karnak I, Aksöz E, Ekinci S, etal. Increased mater­nal intraabdominal pressure alters the contractile properties of fetal rabbit bladder. J Pediatr Surg. 2008;43:1711–7.
44. Tanyel F. Urinary tract anomalies and dysfunc­tional voiding: a spectrum dictated by the inuence of amniotic pressure upon fetal urodynamics. Med Hypotheses. 2000;54:140–5.
45. Cotechini T, Komisarenko M, Sperou A, Macdonald-Goodfellow S, Adams MA, Graham CH. Inammation in rat pregnancy inhibits spiral artery remodeling leading to fetal growth restric­tion and features of preeclampsia. J Exp Med. 2014;211(1):165–79.
46. Renaud SJ, Cotechini T, Quirt JS, Macdonald­Goodfellow SK, Othman M, Graham CH. Spontaneous pregnancy loss mediated by abnormal maternal inammation in rats is linked to decient uteroplacental perfusion. J Immunol. 2011;186(3):1799–808.
47. François Mauriceau. n.d.. https://en.wikipedia.org/
wiki/François_Mauriceau.
48. Chesley L. History and epidemiology of preeclampsia- eclampsia. Clin Obstet Gynecol. 1984;27:801–20.
49. Paramore R. Eclampsia and its incidence. Proc R Soc Med. 1922;15:14–6.
50. Contreras F, Fouillioux C, Bolivar A, et al. Endothelium and hypertensive disorders in preg­nancy. Am J Ther. 2003;10:415–22.
51. Sugerman H.Hypothesis: preeclampsia is a venous disease secondary to an increased intra-abdominal pressure. Med Hypotheses. 2011;77:841–9.
52. Ünsal MA, İnce Ü, Cengiz S, Karahan SC, Aran T.The relationship between intraabdominal hyper­tension and preeclampsia. Gynecol Obstet Reprod Med. 2017;23:1–5.
53. Silasi M, Cohen B, Karumanchi SA, Rana S. Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia. Obstet Gynecol Clin N Am. 2010;37:239–53.
54. Dart BW, Cockerham WT, Torres C, etal. A novel use of recombinant factor VIIa in HELLP syn­drome associated with spontaneous hepatic rupture and abdominal compartment syndrome. J Trauma. 2004;57:171–4.
55. Kumar P, Sait SF, Sharma A, Kumar M.Ovarian hyperstimulation syndrome. J Hum Reprod Sci. 2011;4:70–5.
56. Madill JJ, Mullen NB, Harrison BP. Ovarian hyperstimulation syndrome: a potentially fatal complication of early pregnancy. J Emerg Med. 2008;35:283–6.
57. Timmons D, Montrief T, Koyfman A, Long B. Ovarian hyperstimulation syndrome: a review for emergency clinicians. Am J Emerg Med. 2019;37(8):1577–84.
58. Chen C-D, Wu M-Y, Chao K-H, et al. Update on management of ovarian hyperstimulation syndrome. Taiwan J Obstet Gynecol. 2011;50:2–10.
59. Tollan A, Holst N, Forsdahl F, Fadnes HO, Oian P, Maltau JM. Transcapillary uid dynamics during ovarian stimulation for invitro fertilization. Am J Obstet Gynecol. 1990;162(2):554–8.
60. Balasch J, Arroyo V, Fáabregues F, et al. Neurohormonal and hemodynamic changes in severe cases of the ovarian hyperstimulation syn­drome. Ann Intern Med. 1994;121:27–33.
61. Manau D, Balasch J, Arroyo V, Jiménez W, Fabregues F, Casamitjana R, et al. Circulatory dysfunction in asymptomatic in vitro fertilization patients. Relationship with hyperestrogenemia and activity of endogenous vasodilators. J Clin Endocrinol Metab. 1998;83(5):1489–93.
62. Veisi F, Zangeneh M, Malekkhosravi S, Rezavand N. Abdominal compartment syndrome due to OHSS.J Obstet Gynecol India. 2013;53:350–3.
63. Scott JS.Pregnancy toxemia associated with hydrops foetalis, hydatidiform mole and hydramnios. BJOG. 1958;65(5):689–701.
64. Page E.The relation between hydatid moles, relative ischemia of the gravid uterus, and the placental origin of eclampsia. Am J Obstet Gynecol. 1939;37:291–3.
65. Peparini N, Di Matteo FM, Silvestri A, et al. Abdominal hypertension in Meigs’ syndrome. Eur J Surg Oncol. 2008;34:938–42.
66. Kron IL, Harman PK, Nolan SP.The measurement of intra-abdominal pressure as a criterion for abdom­inal re-exploration. Ann Surg. 1984;199:28–30.
References
https://t.me/medicina_free
71
67. Friedman JD, Ramsey PS, Ramin KD, Berry C.Pneumoamnion and pregnancy loss after second trimester laparoscopic surgery. Obstet Gynecol. 2002;99:512–3.
68. Lachman E, Schienfeld A, Voss E, etal. Pregnancy and laparoscopic surgery. J Am Assoc Gynecol Laparosc. 1999;6:347–51.
69. Schwartzberg BS, Conyers JA, Moore JA.First tri­mester of pregnancy laparoscopic procedures. Surg Endosc. 1997;11:1216–7.
70. Hunter JG, Swanstrom L, Thornburg K. Carbon dioxide pneumoperitoneum induces fetal acidosis in a pregnant ewe model. Surg Endosc. 1995;9:272–9.
71. Soper NJ, Hunter JG, Petrie RH. Laparoscopic cholecystectomy during pregnancy. Surg Endosc. 1992;6:115–7.
72. Liu Y-X, Zhang Y, Huang J-F, Wang L. Meta­analysis comparing the safety of laparoscopic and open surgical approaches for suspected adnexal mass during the second trimester. Int J Gynaecol Obstet. 2017;136:272–9.
73. Nasioudis D, Tsilimigras D, Economopoulos KP. Laparoscopic cholecystectomy during preg­nancy: a systematic review of 590 patients. Int J Surg. 2016;27:165–75.
74. Segev L, Segev Y, Rayman S, Shapiro R, Nissan A, Sadot E.Appendectomy in pregnancy: appraisal of the minimally invasive approach. J Laparoendosc Adv Surg Techn. 2016;26(11):893–7.
75. Schorr RT. Clinical correspondence. Laparoscopic cholecystectomy and pregnancy. J Laparoendosc Surg. 1993;3:291–3.
76. Shaked G, Twena M, Charuzi I.Laparoscopic chole­cystectomy for empyema of gallbladder during preg­nancy. Surg Laparosc Endosc. 1994;4:65–7.
77. Arvidsson D, Gerdin E. Laparoscopic cholecys­tectomy during pregnancy. Surg Laparosc Endosc. 1991;3:193–4.
78. Nezhat FR, Tazuke S, Nezhat CH, Seidman DS, Phillips DR, Nezhat CR.Laparoscopy during preg­nancy: a literature review. JSLS. 1997;1(1):17–27.
79. Holzman M, Sharp K, Richards W. Hypercarbia during carbon dioxide gas insufation for therapeu­tic laparoscopy: a note of caution. Surg Laparosc Endosc. 1992;2(1):11–4.
80. Wittgen CM, Andrus CH, Fitzgerald SD, Baudendistel LJ, Dahms TE, Kaminski DL. Analysis of the hemodynamic and ventilatory effects of laparoscopic cholecystectomy. Arch Surg. 1991;126(8):991–7.
81. Westerband A, Van De Water J, Amzallag M, Lebowitz PW, Nwasokwa ON, Chardavoyne R, et al. Cardiovascular changes during laparo­scopic cholecystectomy. Surg Gynecol Obstet. 1992;175(6):535–8.
82. Barnard JM, Chafn D, Droste S, Tierney A, Phernetton T.Fetal response to carbon dioxide pneu­moperitoneum in the pregnant ewe. Obstet Gynecol. 1995;85(5 Pt 1):669–74.
83. Surgeons B of G of the S of AG and E.Guidelines for the use of laparoscopy during pregnancy. 2017.
https://www.sages.org/publications/guidelines/ guidelines- for- diagnosis- treatment- and- use- of­laparoscopy- for- surgical- problems- during­pregnancy/.
84. Curet MJ, Vogt DA, Schob O, etal. Effects of CO2 pneumoperitoneum in pregnant ewes. J Surg Res. 1996;63:339–44.
85. Sungler P, Heinerman PM, Steiner H, et al. Laparoscopic cholecystectomy and interventional endoscopy for gallstone complications during preg­nancy. Surg Endosc. 2000;14:267–71.
86. Steinbrook RA, Brooks DC, Datta S.Laparoscopic cholecystectomy during pregnancy. Review of anes­thetic management, surgical considerations. Surg Endosc. 1996;10(5):511–5.
87. Curet MJ.Special problems in laparoscopic surgery. Previous abdominal surgery, obesity, and pregnancy. Surg Clin North Am. 2000;80(4):1093–110.
88. Barnard JM, Chafn D, Droste S, et al. Fetal response to carbon dioxide pneumoperitoneum in the pregnant ewe. Obstet Gynecol. 1995;85:669–74.
89. Nezhat C, Seidman DS, Vreman HJ, etal. The risk of carbon monoxide poisoning after prolonged lapa­roscopic surgery. Obstet Gynecol. 1996;88:771–4.
90. Beebe DS, Swica H, Carlson N, Palahniuk RJ, Goodale RL. High-levels of carbon-monoxide are produced by electro-cautery of tissue dur­ing laparoscopic cholecystectomy. Anesth Analg. 1993;77(2):338–41.
91. Barrett WL, Garber SM.Surgical smoke– a review of the literature. Is this just a lot of hot air? Surg Endosc. 2003;17:979–87.
92. Luks FI, Deprest J, Marcus M, etal. Carbon dioxide pneumoamnios causes acidosis in fetal lamb. Fetal Diagn Ther. 1994;9:105–9.
93. Kashtan J, Green JF, Parsons EQ, Holcroft JW. Hemodynamic effects of increased abdominal pressure. J Surg Res. 1981;30(3):249–55.
94. Gannedahl P, Odeberg S, Brodin LA, Sollevi A.Effects of posture and pneumoperitoneum during anaesthesia on the indices of left ventricular lling. Acta Anaesthesiol Scand. 1996;40(2):160–6.
95. Ho HS, Saunders CJ, Gunther RA, Wolfe BM.Effector of hemodynamics during laparoscopy: CO2 absorption or intraabdominal pressure? J Surg Res. 1995;59:497–503.
96. Joris JL, Noirot DP, Legrand MJ, Jacquet NJ, Lamy ML. Hemodynamic changes during laparoscopic cholecystectomy. Anesth Analg. 1993;76:1067–71.
97. Curet MJ, Allen D, Josloff RK, Pitcher DE, Curet LB, Miscall BG, et al. Laparoscopy during preg­nancy. Arch Surg. 1996;131(5):546–50.
98. Diettrich NA, Kaplan G. Surgical considerations in the contemporary management of biliary tract disease in the postpartum period. Am J Surg. 1998;176:251–3.
72
https://t.me/medicina_free
3 Increased Intra-abdominal Pressure
99. Buser K. Laparoscopic surgery in the pregnant patient– one surgeon’s experience in a small rural hospital. JSLS. 2002;6:121–4.
100. Nagai H, Kondo Y, Yasuda T, Kasahara K, Kanazawa K. An abdominal wall-lift method of laparoscopic cholecystectomy without peritoneal insufation. Surg Laparosc Endosc. 1993;3:175–9.
101. Smith RS, Fry WR, Tsoi EK, etal. Gasless lapa­roscopy and conventional instruments: the next phase of minimally invasive surgery. Arch Surg. 1993;128:1102–7.
102. Akira S, Yamanaka A, Ishihara T, et al. Gasless laparoscopic ovarian cystectomy during pregnancy: comparison with laparotomy. Am J Obstet Gynecol. 1999;180:554–7.
103. Uen Y, Liang A, Lee H.Gasless laparoscopic cho­lecystectomy during pregnancy. Formosan J Surg. 2001;34:126–31.
104. Sesti F, Pietropolli A, Sesti FF, Piccione E.Gasless laparoscopic surgery during pregnancy: evaluation of its role and usefulness. Eur J Obstet Gynecol Reprod Biol. 2013;170:8–12.
105. Takeda A, Kitami K, Shibata M.Magnetic resonance imaging and gasless laparoendoscopic single-site surgery for the diagnosis and management of iso­lated tubal torsion with a paratubal cyst at 31 weeks of gestation: a case report and literature review. J Obstet Gynaecol Res. 2020;46(8):1450–5.
106. Tanaka H, Futamura N, Takubo S, Toyoda N. Gasless laparoscopy under epidural anesthesia for adnexal cysts during pregnancy. J Reprod Med. 1999;44:929–32.
107. Murakami T, Noda T, Okamura C, etal. Cul-de-sac packing with a metreurynter in gasless laparoscopic cystectomy during pregnancy. J Am Assoc Gynecol Laparosc. 2003;10:421–3.
108. Oguri H, Taniguchi K, Fukaya T. Gasless laparo­scopic management of ovarian cysts during preg­nancy. Int J Gynaecol Obstet. 2005;91:258–9.
109. Iafrati MD, Yarnell R, Schwaitzberg SD. Gasless laparoscopic cholecystectomy in pregnancy. J Laparoendosc Surg. 1995;5:127–30.
110. Melgrati L, Damiani A, Franzoni G, etal. Isobaric (gasless) laparoscopic myomectomy during preg­nancy. J Minim Invasive Gynecol. 2005;12:379–81.
111. Schmidt T, Nawroth F, Foth D, etal. Gasless lapa­roscopy as an option for conservative therapy of adnexal pedical torsion with twin pregnancy. J Am Assoc Gynecol Laparosc. 2001;8:621–2.
112. Römer T, Bojahr B, Schwesinger G. Treatment of a torqued hematosalpinx in the thirteenth week of pregnancy using gasless laparoscopy. J Am Assoc Gynecol Laparosc. 2002;9:89–92.
113. Sahu L, Bupathy A.Evisceration of pregnant uterus through the incisional hernia site. J Obstet Gynaecol Res. 2006;32(3):338–40.
114. Kumar R, Sonika A, Kaberi B, etal. Gravid uterus in an incisional hernia leading to burst abdomen. Int J Gynecol Obstet. 2004;5(1).
115. Ahmed A, Stephen G, Ukwenya Y.Spontaneous rup­ture of umbilical hernia in pregnancy: a case report. Oman Med J. 2011;26(4):285–7.
116. Wydell S. Umbilical hernia in pregnancy. BMJ. 1963;1:1413–4.
117. Asukai K, Kashiwazaki M, Koizumi K, etal. A case report of a 19-week gravid patient with a dehisced abdominal wound and treated with V.A.C.ATS(®) Therapy System. Int Wound J. 2016;13:992–5.
118. Okpala AM, Debrah SA, Mouhajer M.Burst abdo­men in pregnancy: a proposed management algo­rithm. Ghana Med J. 2016;50:115–8.
119. El-Agwany AS, Fouad AM. Partial wound dehis­cence after midline laparotomy: a complication after tubo-ovarian abscess evacuation with pregnancy. Arch Perinatal Med. 2014;20:229–31.
120. Sivabalasubramaniam G, Sagili H, Dasari P, Gowda M. Burst abdomen: an unusual compli­cation of silicosis in pregnancy. BMJ Case Rep. 2015;2015:bcr2014207132.
121. Sun L, Li W, Sun F, Geng Y, Tong Z, Li J. Intra­abdominal pressure in third trimester pregnancy complicated by acute pancreatitis: an observational study. BMC Pregnancy Childbirth. 2015;15:223.
122. Logrado A, Constantino J, Pereira J, Casimiro C.Laparostomy during pregnancy: a case report. Int J Surg Case Rep. 2018;51:120–4.
123. Turnock AR, Fleischer BP, Carney MJ, Vanderlan WB. Perforated second trimester appendicitis with abdominal compartment syndrome managed with negative pressure wound therapy and open abdomen. J Surg Case Rep. 2016;2016(6):rjw101.
124. Vera ME, Pérez CA, Lattus OJ, Barrera CV, Campaña VG, Kattan MJ, et al. Rotura hepatica asociada a preeclampsia severa y sindrome HELLP: manejo y tratamiento con tamponamiento intraab­dominal temporal de compresas. Rev Chil Obstet Ginecol. 2004;69:319–27.
125. Dessole S, Capobianco G, Virdis P, Rubattu G, Cosmi E, Porcu A.Hepatic rupture after cesarean section in a patient with HELLP syndrome: a case report and review of the literature. Arch Gynecol Obstet. 2007;276:189–92.
126. Cimbanassi S, Aseni P, Mariani A, Sammartano F, Bonacina E, Chiara O.Spontaneous hepatic rupture during pregnancy in a patient with peliosis hepatis. Ann Hepatol. 2015;14(4):553–8.
127. Escobar Vidarte MF, Montes D, Pérez A, Loaiza­Osorio S, Calvache AJN. Hepatic rupture associ­ated with preeclampsia, report of three cases and literature review. J Matern Fetal Neonatal Med. 2019;32:2767–73.
128. Richter CE, Saber S, Thung SF.Eclampsia compli­cated by abdominal compartment syndrome. Am J Perinatol. 2009;26:751–3.
129. Swain HL, Bahidar B, Das L.Eventration of gravid uterus. J Obstet Gyecol India. 1995;45:771–2.
130. Kirkpatrick AW, Brenneman FD, McLean RF, etal. Is clinical examination an accurate indicator of
References
https://t.me/medicina_free
73
raised intra-abdominal pressure in critically injured patients. Can J Surg. 2000;43:207–11.
131. Cil T.A tale of two syndromes: ovarian hyperstimu­lation and abdominal compartment: case report. Hum Reprod. 2000;15:1058–60.
132. Delvigne A, Rozenberg S.Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS). Hum Reprod Update. 2003;9(1):77–96.
133. De Waele JJ, Hoste EAJ, Malbrain MLNG. Decompressive laparotomy for abdominal compartment syndrome - a critical analysis. Crit Care. 2006;10(2):R51.
134. Cheatham ML, Safcsak K, Brzezinski SJ, Lube MW. Nitrogen balance, protein loss, and the open abdomen. Crit Care Med. 2007;35:127–31.
135. Cothren CC, Moore EE, Ciesla DJ, Johnson JL, Moore JB, Haenel JB, et al. Postinjury abdominal compartment syndrome does not preclude early enteral feeding after denitive closure. Am J Surg. 2004;188(6):653–8.
136. Byrnes MC, Reicks P, Irwin E.Early enteral nutri­tion can be successfully implemented in trauma patients with an “open abdomen.”. Am J Surg. 2010;199(3):359–63.
137. Dissanaike S, Pham T, Shalhub S, Warner K, Hennessy L, Moore EE, et al. Effect of immedi­ate enteral feeding on trauma patients with an open abdomen: protection from nosocomial infections. J Am Coll Surg. 2008;207(5):690–7.
138. Doig GS, Heighes PT, Simpson F, Sweetman EA. Early enteral nutrition reduces mortality in trauma patients requiring intensive care: a meta­analysis of randomised controlled trials. Injury. 2011;42(1):50–6.
139. Pacheco LD, Saade GR, Hankins GDV.Mechanical ventilation during pregnancy: sedation, analgesia, and paralysis. Clin Obstet Gynecol. 2014;57:844–50.
140. Hakobyan RV, Mkhoyan GG. Epidural analgesia decreases intraabdominal pressure in postoperative patients with primary intra-abdominal hypertension. Acta Clin Belg. 2008;63:86–92.
141. Mullens W, Abrahams Z, Skouri HN, Francis GS, Taylor DO, Starling RC, et al. Elevated intra­abdominal pressure in acute decompensated heart failure. A potential contributor to worsening renal function? J Am Coll Cardiol. 2008;51:300–6.
142. Malgras B, Prunet B, Lesaffre X, Boddaert G, Travers S, Cungi PJ, etal. Damage control: concept and implementation. J Visc Surg. 2017;154(Suppl
1):S19–29.
143. Hwabejire JO, Nembhard CE, Oyetunji TA, Seyoum T, Siram SM, Cornwell EE, etal. Abdominal com­partment syndrome in traumatic hemorrhagic shock: is there a uid resuscitation inection point associated with increased risk? Am J Surg. 2016;211:733–8.
144. Deenichin GP.Abdominal compartment syndrome. Surg Today. 2008;38(1):5–19.
145. Papavramidis TS, Marinis AD, Pliakos I, Kesisoglou I, Papavramidou N. Abdominal compartment syn­drome - intra-abdominal hypertension: dening, diagnosing, and managing. J Emerg Trauma Shock. 2011;4(2):279–91.
146. Sartelli M, Abu-Zidan FM, Ansaloni L, Bala M, Beltrán MA, Bif WL, etal. The role of the open abdomen procedure in managing severe abdominal sepsis: WSES position paper. World J Emerg Surg. 2015;10(1):35.
147. Schein M, Saadia R, Jamieson JR, Decker GA.The “sandwich technique” in the management of the open abdomen. Br J Surg. 1986;73(5):369–70.
148. Aboutanos SZ, Aboutanos MB, Malhotra AK, Duane TM, Ivatury RR.Management of a pregnant patient with an open abdomen. J Trauma. 2005;59:1052–6.
149. Kreis BE, de Mol van Otterloo JCA, Kreis RW.Open abdomen management: a review of its history and a proposed management algorithm. Med Sci Monit. 2013;19(1):524–33.
150. Yetisir F, Sarer AE, Acar HZ, Osmanoglu G, Özer M, Yaylak F.Management of a septic open abdomen patient with spontaneous jejunal perforation after emergent C/S with confounding factor of mild acute pancreatitis. Case Rep Surg. 2016;2016:7153579.
151. Jernigan TW, Fabian TC, Croce MA, Moore N, Pritchard FE, Minard G, etal. Staged management of giant abdominal wall defects: acute and long-term results. Ann Surg. 2003;238(3):347–9.
152. Staszewicz M, Marty F, Bettschart VWC.Damage control surgery by keeping the abdomen open during pregnancy: favorable outcome, a case report. World J Emerg Surg. 2009;24(4):33.
153. Shapiro SB, Mumme DE.Use of negative pressure wound therapy in the management of wound dehis­cence in a pregnant patient. Wounds. 2008;20:46–8.
154. Morris JA, Rosenbower TJ, Jurkovich GJ, Hoyt DB, Harviel JD, Knudson MM, et al. Infant sur­vival after cesarean section for trauma. Ann Surg. 1996;223(5):481–8; discussion 488–91.
155. Sugrue M, Jones F, Deane SA, Bishop G, Bauman A, Hillman K.Intra-abdominal hypertension is an inde­pendent cause of postoperative renal impairment. Arch Surg. 1999;134(10):1082–5.
156. Van Brunschot S, Schut AJ, Bouwense SA, Besselink MG, Bakker OJ, Van Goor H, etal. Abdominal com­partment syndrome in acute pancreatitis: a system­atic review. Pancreas. 2014;43:665–74.
157. Marshalov DV, Salov IA, Shifman EM, Petrenko AP.Pilot study of the inuence of intra-abdominal pressure of parturient women with obesity on the neurologic status of a newborn. Ann Clin Lab Res. 2017;5:2.
Acute Abdomen-Induced Preterm
https://t.me/medicina_free
Labor
4
Abstract
The specic issue with acute abdomen during pregnancy is that many underlying conditions result in inammation and infection, which raise prostaglandin levels, which are crucial for normal labor progress. Therefore it is mandatory to stop the increased preterm pro­duction of prostaglandins. The only solution is early diagnosis and treatment of acute abdominal conditions during pregnancy. In addition to inammation, abdominal trauma is also an issue. It can cause placental abrup­tion and preterm labor. In addition to these two most common groups of the acute abdo­men during pregnancy, other important topics are discussed. These include maternal and fetal stress as a result of any cause of acute abdomen during pregnancy and the problem of adequate perioperative nutrition. Inadequate maternal nutrition results in dis­eases with a prolonged course before thera­peutic interventions such as conservatively treated acute cholecystitis or acute pancreati­tis. Prolonged inadequate postoperative nutri­tion is seen after many surgical procedures, especially those requiring bowel resections or reoperations. Therefore underlying pathology should be diagnosed and treated early in the course of the disease. Additional measures for detecting and preventing preterm labor should be instituted as early as possible.
4.1 Denitions
Preterm labor (PTL) is a process of regular con­tractions accompanied by the cervical change before 37 completed weeks of gestation. PTL can be:
• Induced for maternal or fetal indications
(drug-induced or delivery by elective or emer­gent Cesarean section (CS)),
• Spontaneous PTL:
– cervical dilation and intact membranes, – preterm premature rupture of the mem-
branes (PPROM).
PPROM is dened as the spontaneous rupture of the membranes at less than 37weeks’ gesta­tion at least 1h before the onset of contractions. About 30–35% of PTLs are indicated, 40–45% follow spontaneous PTL, and 25–30% follow PPROM [1, 2].
Preterm birth (PTB) is subdivided into extremely preterm (<28 weeks), very preterm (28–32 weeks), and moderate to late PTB (32– 36weeks) [3]. Today, births can occur as early as 16weeks of gestation, making the line between spontaneous abortion and spontaneous PTB more challenging.
PTL can be initiated by multiple mecha­nisms—infection/inammation, uteroplacental ischemia or bleeding, uterine trauma, uterine overdistension, or stress [4].
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2023 G. Augustin, Acute Abdomen During Pregnancy, https://doi.org/10.1007/978-3-031-26021-6_4
75
76
https://t.me/medicina_free
4 Acute Abdomen-Induced Preterm Labor
4.2 Physiology ofLabor
Human labor is an inammatory, three-step pro­cess characterized by uterine contractility, cervi­cal ripening, and membrane activation/rupture [5]. The fundamental difference between the term labor and PTL is that the former results from the “physiologic activation” of this com­mon pathway. In contrast, PTL results from either early idiopathic activation of the normal labor or disease process (“pathologic activation”) that activates one or more of the components of the common pathway [5]. Monocytes and neutro­phils are primed in the peripheral blood associ­ated with term and PTL [6]. These cells inltrate the human myometrium and cervix during spon­taneous term labor, which is associated with a signicant increase in interleukin (IL -1β, IL-6, and IL-8) gene expression [7].
The common pathway of parturition includes the anatomic, biochemical, immunologic, endocri­nologic, and clinical events in the mother and fetus at term or PTL. Fetal cortisol is central to labor initiation [8]. As parturition nears, the fetal- adrenal axis becomes more sensitive to the adrenocortico­tropic hormone, increasing cortisol secretion. Fetal cortisol stimulates placental 17α-hydroxylase activity, decreasing progesterone secretion and increasing estrogen production. The reversal in the estrogen/progesterone ratio results in increased prostaglandin formation, initiating a cascade of events resulting in labor (see Sect. 4.2.4). During pregnancy, the uterus is maintained in a relatively quiescent state through the separate or combined autocrine–paracrine actions of inhibitors such as progesterone, prostacyclin (PGI2), relaxin, para­thyroid hormone-related peptide, calcitonin gene­related peptide, adrenomedullin, vasoactive intestinal peptide, nitric oxide, and corticotrophin­releasing hormone, which may inhibit and stimu­late uterine contractility [9].
Activation of the uterine components of the common pathway of parturition may be synchro­nous or asynchronous. Synchronous activation results in clinical spontaneous PTL. Asynchronous activation results in (1) predominant activation of the membranes that leads to PPROM, (2) of the cervix to cervical insufciency, and (3) that of the
myometrium to preterm uterine contractions without cervical change or rupture of membranes.
4.2.1 Myometrial Contractility
Increased cell-to-cell communication is respon­sible for the effectiveness of myometrial contrac­tility during labor. Gap junctions develop in the myometrium just before labor and disappear shortly after delivery [10, 11]. Gap junction for­mation and the expression of the gap junction protein, connexin-43, in human myometrium are similar in both term labor and PTL [1214]. The appearance of gap junctions and increased expression of connexin-43 are part of the molec­ular and cellular events responsible for switching from contractures to contractions before the onset of parturition. Estrogen, progesterone, and pros­taglandins regulate gap junction formation and inuence the expression of connexin-43 [1517]. Connexin-43 and other distinct contraction­associated proteins are characteristic of this phase of parturition [1820]. α-actin was expressed in the myometrium in early pregnancy, whereas γ-actin was highly expressed by the myometrium with a contractile phenotype.
Myometrial phenotype programming [21] and sequential phenotypic changes start from an early proliferative phase. It is characterized by bromo­deoxyuridine incorporation, the proliferating cell nuclear antigen expression level, increased IGF-I signaling, and the expression of anti-apoptosis factors such as Bcl-2 [21]. An intermediate syn­thetic phase is characterized by increased cell size and synthesis/deposition of the interstitial matrix that forms the ground substance of the myometrium [2224]. A late contractile phase is characterized by the upregulation of contraction­associated proteins, oxytocin, and prostaglandin receptors in which the cells are committed to labor [14, 25, 26]. This phenotypic program­ming is accomplished through two separate but integrated pathways: an endocrine cascade com­prising the fetal hypothalamic-pituitary-adre­nal-placental axis and a mechanical pathway in which fetal growth imposes tension on the uter-
4.2 Physiology ofLabor
https://t.me/medicina_free
77
ine wall [9]. Abnormal myometrial stretch (i.e., polyhydramnios, multiple gestations) promotes the expression of gap junction proteins, oxytocin receptors, and prostaglandins in the amnion myo­metrium and cervical cells [27]. These alterations promote uterine activity and the degradation of the extracellular matrix, thereby facilitating cer­vical ripening and ROM.
4.2.2 Cervical Remodeling
The changes in the cervix include: (1) softening, (2) ripening, (3) dilatation, and (4) postpartum repair [28]. The molecular and cellular basis for cervical remodeling during pregnancy and partu­rition primarily depends on regulating extracel­lular matrix components [28, 29]. Leukocytosis in the cervix responds to increasing local levels of estrogens derived from fetal adrenal precur­sors. This results in the release of metalloprote­ases/collagenases, driving cervical ripening and dilatation. It facilitates access by cervicovaginal microora to the surface of the membranes cov­ering the cervical os, furthering the inammatory response in the amniotic cavity. Hyaluronidase activity increases in the cervix due to functional progesterone withdrawal, degrading hyaluronan leading to disaggregation of polymers, inamma­tory activation, and cervical ripening [30]. The softening of the cervix begins in early pregnancy. The tensile strength of the softened cervix appears to be maintained by an increase in colla­gen synthesis and growth of the cervix. Cervical ripening is characterized by a decreased concen­tration of collagen and the dispersion of collagen brils. The latter has been attributed to glycos­aminoglycans, such as decorin and hyaluronan, which promote the hydration of cervical tissue and dispersion of collagen bers [29]. Dilation of the cervix is an inammatory phenomenon with an inux of macrophages, neutrophils, and matrix degradation [31, 32]. Chemokines such as IL-8 [33, 34] and S100 proteins [35, 36] attract inam- matory cells, which, in turn, release pro­inammatory cytokines, including IL-1β [37, 38] and tumor necrosis factor-α (TNF-α) [36], which can activate the nuclear factor (NF)-κB signaling
pathway. NF-κB can block progesterone receptor­mediated actions [39]. Progesterone has been implicated in regulating cervical remodeling because the administration of antiprogestins in the mid-trimester and, at term, induces cervical ripening [28, 40, 41].
4.2.3 Decidual/Membrane
Activation
During pregnancy, the chorioamnionic mem­branes fuse with the decidua. In preparation for delivery, biochemical events lead to separation and postpartum expulsion of the membranes. Fibronectins are a family of essential extracellu­lar matrix proteins. The degradation of a heavily glycosylated form of cellular bronectin—fetal bronectin—present at the chorionic-decidual interface leads to its release into cervical and vaginal secretions immediately before term or PTL [4244].
Enzymatic activity of matrix metalloprotein­ases (MMPs) and other proteases has been impli­cated in the process of rupture of membranes and parturition with intact membranes (with and without infection) [45, 46]. The precise decidual/ membrane activation mechanism remains unknown, but extracellular matrix-degrading enzymes, such as the MMPs and elastase, have a role. There is increased availability of MMP-1 (interstitial collagenase) [47], MMP-8 (neutro­phil collagenase) [47], MMP-9 (gelatinase-B) [48], and neutrophil elastase [49] in the amniotic uid of women with PPROM, compared with women in PTL with intact membranes. Plasmin has also been implicated [44] because it can degrade type III collagen, bronectin, and lam­inin [50]. A role for tissue inhibitors of MMPs (TIMPs) has also been postulated.
4.2.4 Prostaglandins
andParturition
Prostaglandins are the key mediators for the onset of labor [51]. They induce myometrial contractil­ity [51, 52], changes in extracellular matrix